Quantifying COPD as a risk factor for cardiac disease in a primary prevention cohort
Maclagan LC, Croxford R, Chu A, Sin D, Udell JA, Lee DS, Austin PC, Gershon AS. Eur Respir J. 2023; Jun 29 [Epub ahead of print].
Publications
Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty
Wang TF, Grubic N, Carrier M, Canney M, Delluc A, Hundemer GL, Knoll G, Lazo-Langner A, Massicotte-Azarniouch D, Tanuseputro P, Sood MM. Am J Hematol. 2023; Jun 21 [Epub ahead of print].
Statin use and stroke rate in older adults with atrial fibrillation: a population-based cohort study
Shweikialrefaee B, Ko DT, Fang J, Pang A, Austin PC, Dorian P, Singh SM, Jackevicius CA, Tu K, Lee DS, Abdel-Qadir H.
Prescribing patterns and factors associated with sodium-glucose cotransporter-2 inhibitor prescribing in patients with diabetes mellitus and atherosclerotic cardiovascular disease
Ozaki AF, Ko DT, Chong A, Fang J, Atzema CL, Austin PC, Stukel TA, Tu K, Udell JA, Naimark D, Booth GL, Jackevicius CA. CMAJ Open. 2023; 11(3):E494-503. Epub 2023 Jun 13.
Short- and long-term outcomes in patients with thrombophilia undergoing transcatheter closure of patent foramen ovale
Abrahamyan L, Stefanescu Schmidt AC, Dharma C, Everett K, Lee DS, Canthiya L, Kolker S, Horlick E. JACC Cardiovasc Interv. 2023; 16(11):1360-6. Epub 2023 Jun 12.
Association of beta-blocker therapy with cardiovascular outcomes in patients with stable ischemic heart disease
Godoy LC, Farkouh ME, Austin PC, Shah BR, Qiu F, Jackevicius CA, Wijeysundera HC, Krumholz HM, Ko DT. J Am Coll Cardiol. 2023; 81(24):2299-311. Epub 2023 Jun 12.
Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis
Situ M, Schwarz UI, Zou G, McArthur E, Kim RB, Garg AX, Sarma S. Eur J Health Econ. 2023; May 17 [Epub ahead of print].
Safety and effectiveness of rivaroxaban versus warfarin across GFR levels in atrial fibrillation: a population-based study in Australia and Canada
Ha JT, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Lam D, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M. Kidney Med. 2023; 5(7):100675. Epub 2023 May 16.
Sex-based differences in severe outcomes, including cardiovascular hospitalization, in adults with COVID-19 in Ontario, Canada
Behrouzi B, Sivaswamy A, Chu A, Ferreira-Legere LE, Abdel-Qadir H, Atzema CL, Jackevicius C, Kapral MK, Wijeysundera HC, Farkouh ME, Ross HJ, Ha ACT, Tadrous M, Paterson M, Gershon AS, Dzavík V, Fang J, Kaul P, van Diepen S, Goodman SG, Ezekowitz JA, Bainey KR, Ko DT, Austin PC, McAlister FA, Lee DS, Udell JA. JACC Adv. 2023; May 10 [Epub ahead of print].
New hypertension after pregnancy in patients with heart disease
Siu SC, Lee DS, Fang J, Austin PC, Silversides CK. J Am Heart Assoc. 2023; 12(10):e029260. Epub 2023 May 9.